| 1 |
34042026 | Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy. | 2022 |
1 |
| 2 |
34353250 | Current Perspective of COVID-19 on Neurology: A Mechanistic Insight. | 2022 |
1 |
| 3 |
34370633 | Molecular Modeling Targeting Transmembrane Serine Protease 2 (TMPRSS2) as an Alternative Drug Target Against Coronaviruses. | 2022 |
1 |
| 4 |
34561887 | Proteolytic activation of SARS-CoV-2 spike protein. | 2022 Jan |
1 |
| 5 |
34826419 | Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells. | 2022 Jan |
1 |
| 6 |
34862332 | A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity. | 2022 Mar 1 |
2 |
| 7 |
34915414 | In vitro interaction of potential antiviral TMPRSS2 inhibitors with human serum albumin and cytochrome P 450 isoenzymes. | 2022 Feb |
2 |
| 8 |
34915500 | Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. | 2022 |
1 |
| 9 |
35039793 | Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro. | 2022 |
1 |
| 10 |
35063125 | The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. | 2022 Feb 8 |
1 |
| 11 |
35103351 | Estradiol reduces ACE2 and TMPRSS2 mRNA levels in A549 human lung epithelial cells. | 2022 Feb 1 |
1 |
| 12 |
35104687 | A common TMPRSS2 variant has a protective effect against severe COVID-19. | 2022 May |
1 |
| 13 |
35128036 | Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies. | 2022 |
2 |
| 14 |
35154056 | Integrated Analysis Reveals the Characteristics and Effects of SARS-CoV-2 Maternal-Fetal Transmission. | 2022 |
1 |
| 15 |
35160229 | Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections. | 2022 Jan 31 |
1 |
| 16 |
35170548 | Potential applications of prognostic and immunological marker transmembrane serine proteinase 2 in prediction, prevention and personalized treatment of lung cancer. | 2022 Mar 3 |
1 |
| 17 |
35193695 | Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review. | 2022 Feb 22 |
1 |
| 18 |
35226423 | Soluble ACE2 and TMPRSS2 Levels in the Serum of Asthmatic Patients. | 2022 Feb 28 |
1 |
| 19 |
35277472 | New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts. | 2022 Mar 11 |
1 |
| 20 |
35320487 | Association of androgenetic alopecia with a more severe form of COVID-19 infection. | 2022 Mar 23 |
1 |
| 21 |
35331159 | Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy-effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker. | 2022 Mar 24 |
1 |
| 22 |
35338216 | Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19. | 2022 Mar 25 |
1 |
| 23 |
35344983 | A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. | 2022 May |
1 |
| 24 |
35345416 | Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study. | 2022 Mar 23 |
1 |
| 25 |
35359837 | ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway Biopsies. | 2022 |
1 |
| 26 |
35412356 | Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19. | 2022 Apr 27 |
1 |
| 27 |
35412405 | Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2? | 2022 Apr 26 |
2 |
| 28 |
35430474 | Molecular modelling identification of phytocompounds from selected African botanicals as promising therapeutics against druggable human host cell targets of SARS-CoV-2. | 2022 Jul |
1 |
| 29 |
35455738 | The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19-A Prospective Pilot Study. | 2022 Apr 12 |
1 |
| 30 |
35458558 | Investigations on SARS-CoV-2 Susceptibility of Domestic and Wild Animals Using Primary Cell Culture Models Derived from the Upper and Lower Respiratory Tract. | 2022 Apr 16 |
1 |
| 31 |
35631327 | Camostat Does Not Inhibit the Proteolytic Activity of Neutrophil Serine Proteases. | 2022 Apr 20 |
1 |
| 32 |
32410502 | First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations. | 2021 Jul |
1 |
| 33 |
32452644 | Caution in the management of SARS-CoV-2 infection in males. | 2021 Jan |
1 |
| 34 |
32672528 | Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches. | 2021 Sep |
1 |
| 35 |
32936429 | Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome. | 2021 May |
1 |
| 36 |
32972339 | Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion. | 2021 |
1 |
| 37 |
33035337 | DockCoV2: a drug database against SARS-CoV-2. | 2021 Jan 8 |
1 |
| 38 |
33098835 | Translating bioactive peptides for COVID-19 therapy. | 2021 Jan 5 |
1 |
| 39 |
33130280 | Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies. | 2021 Jan 5 |
1 |
| 40 |
33141332 | What is the significance of the conjunctiva as a potential transmission route for SARS-CoV-2 infections? | 2021 Jan |
1 |
| 41 |
33164230 | Insights into disparities observed with COVID-19. | 2021 Apr |
1 |
| 42 |
33188579 | Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection. | 2021 Apr |
1 |
| 43 |
33239231 | Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19. | 2021 Jan |
2 |
| 44 |
33394891 | Type 2 Immunity and Age Modify Gene Expression of Coronavirus-induced Disease 2019 Receptors in Eosinophilic Gastrointestinal Disorders. | 2021 May 1 |
1 |
| 45 |
33397514 | Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes. | 2021 Jan 4 |
2 |
| 46 |
33505639 | Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2. | 2021 |
1 |
| 47 |
33556871 | An update review of emerging small-molecule therapeutic options for COVID-19. | 2021 May |
1 |
| 48 |
33564221 | Structural modeling and analysis of the SARS-CoV-2 cell entry inhibitor camostat bound to the trypsin-like protease TMPRSS2. | 2021 |
1 |
| 49 |
33570381 | Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19. | 2021 Jun 11 |
1 |
| 50 |
33609069 | Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2. | 2021 Apr |
2 |